Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$686M |
| 2 |
Merck
MRK
|
+$536M |
| 3 |
GoDaddy
GDDY
|
+$330M |
| 4 |
CSX Corp
CSX
|
+$227M |
| 5 |
Aramark
ARMK
|
+$217M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$372M |
| 2 |
DexCom
DXCM
|
+$339M |
| 3 |
Broadcom
AVGO
|
+$321M |
| 4 |
Adobe
ADBE
|
+$280M |
| 5 |
Meta Platforms (Facebook)
META
|
+$273M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.38% |
| 2 | Healthcare | 16.14% |
| 3 | Financials | 13.58% |
| 4 | Industrials | 12.86% |
| 5 | Consumer Discretionary | 11.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Jazz Pharmaceuticals
JAZZ
$16B
| $145M | 0.08% |
864,883
+1,269
| +0.1% | +$218K |
|
302
Kosmos Energy
KOS
$1.47B
| $145M | 0.08% |
15,530,000
-4,750,000
| -23% | -$40.1M |
|
303
Capri Holdings
CPRI
$1.81B
| $145M | 0.08% |
2,117,010
+353,389
| +20% | +$24.7M |
|
304
H.B. Fuller
FUL
$3.03B
| $145M | 0.08% |
2,802,658
-6,839
| -0.2% | -$386K |
|
305
Cboe Global Markets
CBOE
$29.4B
| $145M | 0.08% |
1,508,511
-381,291
| -20% | -$38.4M |
|
306
Walmart Inc
WMT
$887B
| $144M | 0.08% |
4,598,328
-497,271
| -10% | -$15.2M |
|
307
Jones Lang LaSalle
JLL
$15.4B
| $143M | 0.08% |
992,580
+112,487
| +13% | +$17.7M |
|
308
Electronic Arts
EA
$52.4B
| $143M | 0.08% |
1,187,798
-394,699
| -25% | -$50.9M |
|
|
FITB
309
Fifth Third Bancorp
FITB
$51.9B
| $143M | 0.08% |
5,124,801
+249,267
| +5% | +$7.32M |
|
310
JB Hunt Transport Services
JBHT
$26.4B
| $143M | 0.08% |
1,198,333
-51,849
| -4% | -$6.31M |
|
311
Kennametal
KMT
$2.68B
| $143M | 0.08% |
3,271,844
+300,549
| +10% | +$11.9M |
|
312
Labcorp
LH
$24.4B
| $143M | 0.08% |
955,114
-141,297
| -13% | -$21.5M |
|
313
Prosperity Bancshares
PB
$8.76B
| $142M | 0.08% |
2,045,615
-9,570
| -0.5% | -$689K |
|
314
Walt Disney
DIS
$168B
| $141M | 0.08% |
1,202,042
-52,443
| -4% | -$5.84M |
|
|
CMA
315
DELISTED
Comerica
CMA
| $140M | 0.08% |
1,556,210
+264,433
| +20% | +$25.2M |
|
316
Copart
CPRT
$27B
| $140M | 0.08% |
10,893,192
+5,470,356
| +101% | +$81.7M |
|
317
Globe Life
GL
$13.6B
| $140M | 0.07% |
1,611,695
-53,806
| -3% | -$4.65M |
|
318
American Water Works
AWK
$26.5B
| $139M | 0.07% |
1,580,421
-89,185
| -5% | -$7.84M |
|
319
Fastenal
FAST
$54.5B
| $138M | 0.07% |
9,506,756
-574,320
| -6% | -$8.18M |
|
|
ALXN
320
DELISTED
Alexion Pharmaceuticals
ALXN
| $137M | 0.07% |
985,624
-75,765
| -7% | -$9.5M |
|
|
ANSS
321
DELISTED
Ansys
ANSS
| $136M | 0.07% |
730,941
+58,860
| +9% | +$10.5M |
|
|
HI
322
DELISTED
Hillenbrand
HI
| $136M | 0.07% |
2,608,913
-8,521
| -0.3% | -$433K |
|
323
NCR Voyix
VYX
$1.13B
| $134M | 0.07% |
7,694,730
+742,646
| +11% | +$13.2M |
|
324
Scotiabank
BNS
$106B
| $133M | 0.07% |
2,235,862
-86,220
| -4% | -$5.04M |
|
325
Integra LifeSciences
IART
$1.56B
| $132M | 0.07% |
2,009,131
+42,790
| +2% | +$2.66M |
|
Similar funds
Janus Henderson Group's Q3 2018 Portfolio in Review
As of Q3 2018, Janus Henderson Group held 1,505 positions worth $187B, up 6.7% from $175B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Janus Henderson Group's Q3 2018 filing shows 118 new, 660 increased, 620 reduced and 63 closed positions. Its largest new stake was Elanco Animal Health: 1,976,916 shares worth $69M. The largest sale was Biogen, an estimated $372M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.
- Janus Henderson Group's largest Q3 2018 buy was Elanco Animal Health: 1,976,916 shares worth $69M.
- Janus Henderson Group added most to Apple in Q3 2018, an estimated $686M increase.
- Janus Henderson Group's biggest Q3 2018 reduction was Biogen, cutting an estimated $372M.
- Janus Henderson Group fully exited Financial Engines, Inc. in Q3 2018, selling an estimated $190M.
- Janus Henderson Group's ten largest holdings make up 16% of its $187B portfolio in Q3 2018.
- Janus Henderson Group opened 118 new positions and closed 63 in Q3 2018.
- Janus Henderson Group's portfolio value rose 6.7% quarter-over-quarter to $187B.
Based on Janus Henderson Group's 13F filing for Q3 2018, filed 9 Nov 2018.